Market Alert : Uranium Surge and ASX 200 Technical Outlook: Key Resistance Levels in Focus

Felix Gold Secures AU$18 Million to Advance Antimony and Gold Development in Alaska

Felix Gold Limited (ASX: FXG) has raised AU$18 million through a strongly supported placement at AU$0.36 per share, introducing several new institutional investors to the register. The funds will support exploration, feasibility studies, operational expansion and working capital as the Company progresses its bulk sampling plans and near-term production pathway in Alaska’s Fairbanks Gold District.

Recent technical work has confirmed exceptionally high-purity, near-surface stibnite capable of meeting military-grade antimony specifications—an achievement not seen outside China for decades. Felix has identified extensive stibnite veining over more than 250 metres of strike, with additional anomalies and past-producing mines awaiting further drilling.

With permitting for the bulk sample well advanced and more than 180 assays pending, the capital raise strengthens Felix’s balance sheet and ensures it is fully funded to complete resource updates, economic studies and key engineering and permitting workstreams into 2026.

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au